Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in ANIX — Anixa Biosciences Inc

CIK 19617 NEW YORK, NY
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,852
-$20,753 QoQ
Shares Held
2,090
-69.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 62 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. ANIX ranks #344 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in ANIX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,852 2,090
2023-12-31 $26,605 6,857
2023-09-30 $89,235 27,289
2023-06-30 $87,324 27,289
2023-03-31 $24,295 5,650
2022-12-31 $2,762 650
2022-09-30 $3,198 650
2022-06-30 $1,989 650
2022-03-31 $1,781 650
2021-12-31 $1,930 650
2021-09-30 $3,100 650
2021-06-30 $2,522 650
2021-03-31 $3,042 650
2020-12-31 $2,904 946
2020-09-30 $2,327 958
2020-06-30 $2,930 958
2020-03-31 $2,458 1,546